Literature DB >> 25962001

Epigenetic regulation of protein glycosylation.

Vlatka Zoldoš, Srđana Grgurević, Gordan Lauc.   

Abstract

Protein N-glycosylation is an ancient metabolic pathway that still exists in all three domains of life (Archaea, Bacteria and Eukarya). The covalent addition of one or more complex oligosaccharides (glycans) to protein backbones greatly diversifies their structures and makes the glycoproteome several orders of magnitude more complex than the proteome itself. Contrary to polypeptides, which are defined by a sequence of nucleotides in the corresponding genes, the glycan part of glycoproteins are encoded in a complex dynamic network of hundreds of proteins, whereby activity is defined by both genetic sequence and the regulation of gene expression. Owing to the complex nature of their biosynthesis, glycans are particularly versatile and apparently a large part of human variation derives from differences in protein glycosylation. Composition of the individual glycome appears to be rather stable, and thus differences in the pattern of glycan synthesis between individuals could originate either from genetic polymorphisms or from stable epigenetic regulation of gene expression in different individuals. Studies of epigenetic modification of genes involved in protein glycosylation are still scarce, but their results indicate that this process might be very important for the regulation of protein glycosylation.

Entities:  

Year:  2010        PMID: 25962001     DOI: 10.1515/bmc.2010.027

Source DB:  PubMed          Journal:  Biomol Concepts        ISSN: 1868-5021


  7 in total

1.  Classical Galactosaemia and CDG, the N-Glycosylation Interface. A Review.

Authors:  Ashwini Maratha; Hugh-Owen Colhoun; Ina Knerr; Karen P Coss; Peter Doran; Eileen P Treacy
Journal:  JIMD Rep       Date:  2016-08-09

2.  Epigenetic silencing of HNF1A associates with changes in the composition of the human plasma N-glycome.

Authors:  Vlatka Zoldoš; Tomislav Horvat; Mislav Novokmet; Cyrille Cuenin; Ana Mužinić; Maja Pučić; Jennifer E Huffman; Olga Gornik; Ozren Polašek; Harry Campbell; Caroline Hayward; Alan F Wright; Igor Rudan; Katharine Owen; Mark I McCarthy; Zdenko Herceg; Gordan Lauc
Journal:  Epigenetics       Date:  2012-02       Impact factor: 4.528

3.  Evolutional and clinical implications of the epigenetic regulation of protein glycosylation.

Authors:  Tomislav Horvat; Vlatka Zoldoš; Gordan Lauc
Journal:  Clin Epigenetics       Date:  2011-06-14       Impact factor: 6.551

4.  Transcriptional activation of fucosyltransferase (FUT) genes using the CRISPR-dCas9-VPR technology reveals potent N-glycome alterations in colorectal cancer cells.

Authors:  Athanasios Blanas; Lenneke A M Cornelissen; Maximilianos Kotsias; Joost C van der Horst; Henri J van de Vrugt; Hakan Kalay; Daniel I R Spencer; Rad P Kozak; Sandra J van Vliet
Journal:  Glycobiology       Date:  2019-02-01       Impact factor: 4.313

Review 5.  A critical review on serine protease: Key immune manipulator and pathology mediator.

Authors:  S Patel
Journal:  Allergol Immunopathol (Madr)       Date:  2017-02-21       Impact factor: 1.667

6.  Reversibility of membrane N-glycome of HeLa cells upon treatment with epigenetic inhibitors.

Authors:  Tomislav Horvat; Martina Deželjin; Irma Redžić; Darko Barišić; Maja Herak Bosnar; Gordan Lauc; Vlatka Zoldoš
Journal:  PLoS One       Date:  2013-01-15       Impact factor: 3.240

Review 7.  Epigenetic Regulation of Glycosylation in Cancer and Other Diseases.

Authors:  Rossella Indellicato; Marco Trinchera
Journal:  Int J Mol Sci       Date:  2021-03-15       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.